Basic Searches
Searches without any special characters (listed below) will return items that contain the exact value(s) entered in the search field. This means that searching for "ASPIRIN CALCIUM" won't return any items that have "ASPIRIN GLYCINE CALCIUM" because the search term doesn't match exactly.
Boolean Operators
OR - searches with terms separated by " OR " will return items that contain any of the terms in the search.
Example: "ASPIRIN" OR "CALCIUM" will return items that have strings like "ASPIRIN GLYCINE" and "GLYCINE CALCIUM" because they contain at least one of the terms in the search.

AND - searches with terms separated by " AND " will return items that contain all the terms in the search.
Example: "ASPIRIN" AND "CALCIUM" won't return items that have strings "ASPIRIN GLYCINE" and "GLYCINE CALCIUM" because neither contain both terms, but it will return "ASPIRIN GLYCINE CALCIUM" because it contains both search terms.
version 2.6.1
Substance Class Protein
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
AN3Y2B4SX4
Record Status Validated
Record Version
Show Definitional References Hide Definitional References
Download
Name Type Language Details References
ZILTIVEKIMAB
Domain Jurisdiction Naming Organization
drug  
INN  
Official Name
English  
COR-001
Code
English  
WBP216
Code
English  
WBP-216
Code
English  
MEDI 5117 [WHO-DD]
Common Name
English  
ZILTIVEKIMAB [INN]
Common Name
English  
COR001
Code
English  
MEDI-5117
Code
English  
MEDI5117
Code
English  
Code System Code Type Description References
INN
11143
Created by admin on Thu Nov 12 21:01:53 EST 2020 , Edited by admin on Thu Nov 12 21:01:53 EST 2020
PRIMARY
CAS
1657037-93-8
Created by admin on Thu Nov 12 21:01:53 EST 2020 , Edited by admin on Thu Nov 12 21:01:53 EST 2020
PRIMARY
FDA UNII
AN3Y2B4SX4
Created by admin on Thu Nov 12 21:01:53 EST 2020 , Edited by admin on Thu Nov 12 21:01:53 EST 2020
PRIMARY
NCI_THESAURUS
C171844
Created by admin on Thu Nov 12 21:01:53 EST 2020 , Edited by admin on Thu Nov 12 21:01:53 EST 2020
PRIMARY
From To
1_22 1_96
2_22 2_96
2_147 2_203
2_223 4_213
2_264 2_324
1_147 1_203
2_370 2_428
3_23 3_88
3_133 3_193
4_23 4_88
4_133 4_193
1_223 3_213
1_229 2_229
1_232 2_232
1_264 1_324
1_370 1_428
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_300
N 2_300
Related Record Type Details References
TARGET -> INHIBITOR
none
Mediator Substance Details
none
Created by admin on Thu Nov 12 21:01:53 EST 2020 , Edited by admin on Thu Nov 12 21:01:53 EST 2020
Related Record Type Details References
ACTIVE MOIETY
none
Mediator Substance Details
none
Created by admin on Thu Nov 12 21:01:53 EST 2020 , Edited by admin on Thu Nov 12 21:01:53 EST 2020
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL 0
Note References
[Validation]WARNING:There are 2 substances with a similar sequence to subunit [3,4]:
(Perform similarity search on subunit [3])
found approximate duplicate (96%) sequence in Subunit [3] of "2372V1TKXK" ("LANADELUMAB")
found approximate duplicate (96%) sequence in Subunit [4] of "2372V1TKXK" ("LANADELUMAB")
Created Thu Nov 12 21:01:53 EST 2020
Created By admin
Last Edited Thu Nov 12 21:01:53 EST 2020
Last Edited By admin
Index Source Text / Citation Source Type Tags Date Accessed File
1 who WHO DRUG DICTIONARY PUBLIC_DOMAIN_RELEASE NOMEN
2 https://adisinsight.springer.com/drugs/800045660 WEB PAGE
3 INN Proposed List 121 INN_LIST PUBLIC_DOMAIN_RELEASE
4 NCIT NCI THESAURUS
5 STN STN (SCIFINDER) NOMEN
6 https://adisinsight.springer.com/drugs/800031230 WEB PAGE
7 GSRS System-generated Validation messages VALIDATION_MESSAGE Thu Nov 12 21:01:44 EST 2020
8 Finkel, Kelsey A., et al. "IL-6 inhibition with MEDI5117 decreases the fraction of head and neck cancer stem cells and prevents tumor recurrence." Neoplasia 18.5 (2016): 273-281. JA PUBLIC_DOMAIN_RELEASE
9 GSRS System-generated Validation messages VALIDATION_MESSAGE Thu Nov 12 21:01:44 EST 2020